Pharmacology In Drug Discovery And Development

Before a drug can be evaluated in clinical trials (on human volunteers), it must undergo rigorous preclinical safety testing. This phase is governed by the principles of , which is mandated by regulatory bodies like the FDA and the EMA.

Where does the drug go? After absorption, the drug travels via blood. Barriers exist. The blood-brain barrier (BBB) is a formidable lipophilic wall. A drug targeting a brain tumor (e.g., for glioblastoma) must be lipid-soluble enough to cross the BBB, yet water-soluble enough to travel in plasma. pharmacology in drug discovery and development

Once in humans, pharmacology runs the show. Before a drug can be evaluated in clinical

The process begins by identifying a biological macromolecule—typically a receptor, enzyme, ion channel, or nucleic acid—whose activity is directly tied to a specific disease state. Pharmacologists use advanced genetic tools (such as CRISPR-Cas9), RNA interference, and disease-specific cell assays to confirm that modulating this target will yield a therapeutic response. Target validation requires proving that the target is "druggable," meaning its physical structure contains distinct binding pockets capable of interacting with chemical or biological entities. 2. High-Throughput Screening (HTS) and Hit Identification After absorption, the drug travels via blood

If you are interested in specific aspects of this topic, I can provide more details on: The difference between and in vivo models. How AI and machine learning are changing drug discovery.